Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Soulières · SciRah

Researcher profile · Semantic Scholar

D. Soulières

Share profile

D. Soulières — researcher profile on SciRah

h-index: 48
Works: 308
Citations: 13K

Most-cited papers

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal‐Cell Carcinoma
B. Rini, E. Plimack, V. Stus, R. Gafanov +23 more
2019New England Journal of Medicine2,768 citations Open access
Semantic Scholar
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial.
T. Powles, E. Plimack, D. Soulières, T. Waddell +16 more
2020The Lancet Oncology601 citations
Semantic Scholar
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
K. Harrington, B. Burtness, R. Greil, D. Soulières +17 more
2022Journal of Clinical Oncology427 citations Open access
Semantic Scholar
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
B. Burtness, D. Rischin, R. Greil, D. Soulières +17 more
2022Journal of Clinical Oncology162 citations Open access
Semantic Scholar
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study.
E. Plimack, T. Powles, V. Stus, R. Gafanov +17 more
2023European Urology146 citations
Semantic Scholar
Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
D. Rischin, K. Harrington, R. Greil, D. Soulières +16 more
2019Journal of Clinical Oncology119 citations
Semantic Scholar
Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for metastatic renal cell carcinoma (mRCC): Outcomes in the combined IMDC intermediate/poor risk and sarcomatoid subgroups of the phase 3 KEYNOTE-426 study.
B. Rini, E. Plimack, V. Stus, R. Gafanov +16 more
2019Journal of Clinical Oncology108 citations
Semantic Scholar
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer
K. Emancipator, Ling-Kang Huang, D. Aurora-Garg, T. Bal +7 more
2020Modern Pathology96 citations Open access
Semantic Scholar
Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma (ccRCC): Results from 42-month follow-up of KEYNOTE-426.
B. Rini, E. Plimack, V. Stus, T. Waddell +16 more
2021Journal of Clinical Oncology85 citations
Semantic Scholar
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
K. Harrington, R. Ferris, M. Gillison, M. Tahara +20 more
2023JAMA Oncology65 citations Open access
Semantic Scholar
Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma: 5-year analysis of KEYNOTE-426.
B. Rini, E. Plimack, V. Stus, R. Gafanov +16 more
2023Journal of Clinical Oncology65 citations
Semantic Scholar
Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced renal cell carcinoma (RCC): Updated analysis of KEYNOTE-426.
E. Plimack, B. Rini, V. Stus, R. Gafanov +16 more
2020Journal of Clinical Oncology54 citations
Semantic Scholar
Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)
S. Pai, S. Faivre, L. Licitra, J. Machiels +7 more
2019Journal of Immunotherapy for Cancer42 citations Open access
Semantic Scholar
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma
H. Bahig, F. Aubin, J. Stagg, Olguta Gologan +13 more
2019BMC Cancer41 citations Open access
Semantic Scholar
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
D. Rischin, K. Harrington, R. Greil, D. Soulières +19 more
2022Oral Oncology39 citations Open access
Semantic Scholar
Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review
A. Lalani, D. Heng, N. Basappa, L. Wood +4 more
2022Therapeutic Advances in Medical Oncology37 citations Open access
Semantic Scholar
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults †
D. Bebb, S. Banerji, N. Blais, P. Desmeules +14 more
2021Current Oncology36 citations Open access
Semantic Scholar
Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma.
J. Bedke, B. Rini, E. Plimack, V. Stus +17 more
2022European Urology33 citations
Semantic Scholar
Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial.
B. Rini, M. Atkins, E. Plimack, D. Soulières +15 more
2021European Urology Oncology29 citations
Semantic Scholar
Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience.
A. Dragomir, S. Nazha, L. Wood, R. Rendon +10 more
2020Urologic oncology29 citations
Semantic Scholar
Management of urachal cancer: A review by the Canadian Urological Association and Genitourinary Medical Oncologists of Canada.
Z. Hamilou, S. North, C. Canil, L. Wood +7 more
2019Canadian Urological Association journal = Journal de l'Association des urologues du Canada29 citations Open access
Semantic Scholar
Quality of Life With Pembrolizumab for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
K. Harrington, D. Soulières, C. le Tourneau, J. Dinis +12 more
2020Journal of the National Cancer Institute27 citations Open access
Semantic Scholar
Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.
R. Hamilton, C. Canil, N. S. Shrem, K. Kuhathaas +16 more
2022Canadian Urological Association journal = Journal de l'Association des urologues du Canada26 citations Open access
Semantic Scholar
Determining generalizability of the Canadian Kidney Cancer information system (CKCis) to the entire Canadian kidney cancer population.
C. Tajzler, S. Tanguay, R. Mallick, Beau Ahrens. +17 more
2020Canadian Urological Association journal = Journal de l'Association des urologues du Canada26 citations Open access
Semantic Scholar
Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021.
C. Canil, A. Kapoor, N. Basappa, G. Bjarnason +18 more
2021Canadian Urological Association journal = Journal de l'Association des urologues du Canada25 citations Open access
Semantic Scholar
Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis.
S. Nazzani, F. Preisser, E. Mazzone, Z. Tian +9 more
2020European Urology Focus24 citations
Semantic Scholar
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non-clear Cell Renal Cell Carcinoma Patients.
S. Luzzago, C. Palumbo, G. Rosiello, S. Knipper +11 more
2020European Urology Focus24 citations
Semantic Scholar
Testicular cancer survivorship: Long-term toxicity and management.
N. S. Shrem, L. Wood, R. Hamilton, K. Kuhathaas +11 more
2022Canadian Urological Association journal = Journal de l'Association des urologues du Canada23 citations Open access
Semantic Scholar
MRI-based R2* mapping in patients with suspected or known iron overload
E. Aslan, Jack W. Luo, A. Lesage, Philippe Paquin +6 more
2021Abdominal Radiology23 citations Open access
Semantic Scholar
Dual Inhibition of Autophagy and PI3K/AKT/MTOR Pathway as a Therapeutic Strategy in Head and Neck Squamous Cell Carcinoma
Monique Bernard, Guillaume B Cardin, Maxime Cahuzac, T. Ayad +9 more
2020Cancers23 citations Open access
Semantic Scholar
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma.
S. Nazzani, F. Preisser, E. Mazzone, M. Marchioni +11 more
2019Clinical Genitourinary Cancer21 citations
Semantic Scholar
Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System.
I. Kushnir, N. Basappa, Sunita Ghosh, A. Lalani +13 more
2021Clinical Genitourinary Cancer20 citations
Semantic Scholar
Management of germ cell tumors during the outbreak of the novel coronavirus disease-19 pandemic: a survey of international expertise centers.
L. Nappi, M. Ottaviano, P. Rescigno, M. Tortora +30 more
2020The Oncologist20 citations Open access
Semantic Scholar
Implementing DPYD*2A genotyping in clinical practice: The Quebec (Canada) experience.
Catherine Jolivet, R. Nassabein, D. Soulières, X. Weng +16 more
2020The Oncologist19 citations Open access
Semantic Scholar
Management of cisplatin-associated toxicities in bladder cancer patients.
A. Désilets, J. Adam, D. Soulières
2020Current Opinion in Supportive and Palliative Care19 citations
Semantic Scholar
KEYNOTE-048: Progression after the next line of therapy following pembrolizumab (P) or P plus chemotherapy (P+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
K. Harrington, D. Rischin, R. Greil, D. Soulières +16 more
202019 citations
Semantic Scholar
More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder
E. Mazzone, F. Preisser, S. Nazzani, Z. Tian +10 more
2019Clinical Genitourinary Cancer19 citations
Semantic Scholar
Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?
E. Mazzone, S. Knipper, F. Mistretta, Z. Tian +10 more
2019Cancer Epidemiology19 citations
Semantic Scholar
Effect of mannitol on acute kidney injury induced by cisplatin
Anne-Marie Bégin, Marie-Lawrence Monfette, Étienne Boudrias-Dalle, E. Lavallée +6 more
2020Supportive Care in Cancer17 citations
Semantic Scholar
Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic.
A. Lalani, K. Chi, D. Heng, C. Kollmannsberger +14 more
2020Canadian Urological Association journal = Journal de l'Association des urologues du Canada16 citations Open access
Semantic Scholar
Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients.
M. Thana, N. Basappa, Sunita Ghosh, C. Kollmannsberger +13 more
2021Clinical Genitourinary Cancer15 citations
Semantic Scholar
Abstract LB-258: Efficacy of first-line (1L) pembrolizumab by PD-L1 combined positive score <1, 1-19, and ≥20 in recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): KEYNOTE-048 subgroup analysis
B. Burtness, D. Rischin, R. Greil, D. Soulières +16 more
2020Bioinformatics, Convergence Science, and Systems Biology15 citations
Semantic Scholar
Increased risk of oropharyngeal cancers mediated by oral human papillomavirus infection: Results from a Canadian study
C. Laprise, S. Madathil, N. Schlecht, G. Castonguay +8 more
2019Head and Neck15 citations
Semantic Scholar
Screening for Cognitive Dysfunction Using the Rowland Universal Dementia Assessment Scale in Adults With Sickle Cell Disease
S. Forté, Florence Blais, M. Castonguay, Nafanta Fadiga +7 more
2021JAMA Network Open14 citations Open access
Semantic Scholar
Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts
Dominick Bossé, Wan-Ling Xie, Xun Lin, R. Simantov +15 more
2020JCO Global Oncology13 citations Open access
Semantic Scholar
Single Nucleotide Polymorphism rs6942067 Is a Risk Factor in Young and in Non-Smoking Patients with HPV Negative Head and Neck Squamous Cell Carcinoma
Guillaume B Cardin, Monique Bernard, H. Bahig, P. Nguyen-Tan +9 more
2019Cancers13 citations Open access
Semantic Scholar
Phase II study of de‐intensified intensity‐modulated radiotherapy and concurrent carboplatin/5‐fluorouracil in lateralized p16‐associated oropharyngeal carcinoma
H. Bahig, L. Lambert, E. Filion, D. Soulières +7 more
2020Head and Neck12 citations
Semantic Scholar
Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for locally advanced or metastatic renal cell carcinoma (mRCC): phase III KEYNOTE-426 study.
T. Powles, E. Plimack, V. Stus, R. Gafanov +16 more
2019Journal of Clinical Oncology12 citations
Semantic Scholar
COVID-19 and Sickle Cell Disease in the Province of Quebec, Canada: Outcomes after Two Years of the Pandemic
M. Castonguay, Nawar Dakhallah, J. Desroches, Marie-Laure Colaiacovo +17 more
2022Journal of Clinical Medicine9 citations Open access
Semantic Scholar
The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease
D. Soulières, Jules Mercier-Ross, C. Fradette, A. Rozova +2 more
2022Annals of Hematology9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Pouliot×13
Invite
F. Pouliot — researcher profile on SciRah
L. Wood×12
Invite
L. Wood — researcher profile on SciRah
B. Melichar×10
Invite
B. Melichar — researcher profile on SciRah
T. Powles×10
Invite
T. Powles — researcher profile on SciRah

×9

Invite

B. Rini — researcher profile on SciRah

Invite

V. Stus — researcher profile on SciRah

Invite

R. Gafanov — researcher profile on SciRah

I. Vynnychenko×9

Invite

I. Vynnychenko — researcher profile on SciRah

D. Borchiellini×9

Invite

D. Borchiellini — researcher profile on SciRah

C. Kollmannsberger×9

Invite

C. Kollmannsberger — researcher profile on SciRah

Invite

E. Plimack — researcher profile on SciRah

Invite

D. Nosov — researcher profile on SciRah